Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |